4th Quarter - Report

IMPACT HEALTH POLICY PARTNERS for HEPATITIS B FOUNDATION

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Provide efforts to increase research to control and cure hepatitis B and other infectious diseases on behalf of the Hepatitis B Foundation and its nonprofit affiliates (Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center). H.R.2617, Consolidated Appropriations Act, 2023.

LobbyistCovered position, as disclosed
ALYSON LEWIS —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2617 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.